JAMA & ARCHIVES
Arch Fam Med
SEARCH
GO TO ADVANCED SEARCH
HOME  PAST ISSUES  TOPIC COLLECTIONS  CME  PHYSICIAN JOBS  CONTACT US  HELP
Institution: CLOCKSS  | My Account | E-mail Alerts | Access Rights | Sign In
  Vol. 4 No. 7, July 1995 TABLE OF CONTENTS
  Archives
  •  Online Features
  Letters to the Editor
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Carisoprodol Should Be a Controlled Substance

Ronald J. Dougherty, MD
State University of New York Syracuse

Arch Fam Med. 1995;4(7):582.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

I read with great interest the letter by Chop1 regarding carisoprodol (Soma), in which the question was raised as to whether this drug should be a controlled substance. I also read with great interest the previous article by Rust et al2 on the same subject. As a physician specializing in addiction medicine, I have no doubt that carisoprodol and its metabolite, meprobamate, should be tightly controlled.

Over the past 24 years of my being involved in the field of chemical dependency, I can truthfully say that somewhere between 10% and 15% of patients referred to me for prescription drug misuse are misusing carisoprodol or meprobamate. Approximately 60% of referrals in 1993 were for abuse of a combination of hydrocodon bitartrate and acetaminophen (Vicodin, Lortab).

Six months ago, I treated a patient who had been a long-term abuser of carisoprodol. This 35-year-old woman had never abused alcohol, cocaine, or . . . [Full Text PDF of this Article]






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1995 American Medical Association. All Rights Reserved.